Founder, Chairman & Managing Director - MSN Group
A modest and compassionate humanitarian dedicated to bringing world class medicines within the economic and geographic reach of millions of patients worldwide, Dr MSN Reddy (popularly known as Dr MSN) is the Founder, Chairman and Managing Director of MSN Group of Companies.
Dr. Manne Satyanarayana Reddy (popularly known as Dr. MSN), is the Founder, Chairman and Managing Director of MSN Group of Companies having its Head Office in Hyderabad, India.
Dr. MSN was born at Gurukunta Village in Mahboobnagar District in the State of Telangana. He pursued his education right from elementary School level to Graduation (Bachelor’s in Sciences) in his native district.
He finished his Master’s Degree in M.Sc (Organic Chemistry) from Osmania University in 1983 and earned his PhD in the year 1988. He accomplished his Post-Doctoral Research in Organic Chemistry from Osmania University in the year 1990.
His career, which began in 1990, saw him rise from a Group Leader to Head - Research and Development in one of the leading Indian Pharmaceutical MNCs before venturing out as an entrepreneur in 2003.
Dr. MSN established MSN Group with an initial Capital of Rs. 5 Crores and with a handful of personnel. His zeal to discover, develop and manufacture safe and innovative medicines and bring them within the affordable reach of the people laid a solid foundation for the organisations growth and success.
Dr. MSN believes that persistence and meticulous execution are essential to success and requires outstanding and committed resources to realise it. And MSN Group takes every care to nurture talent and groom them into high performing teams of professionals, relentlessly striving towards organisational goals.
Under his leadership, MSN Group achieved exponential growth, making it one of the fastest growing Pharma companies bringing world class medicines within the economic and geographic reach of millions across the globe. Today, the group with presence in 65+countries employs about 14,000 personnel of which 2,200 personnel are dedicated to Research & Development.
As a scientist, Dr. MSN is accredited for developing various new molecules for regulatory and semi-regulatory markets following current Good Laboratory Practices (cGLP) and current Good Manufacturing Practices (cGMP). He has to his credit about 350 products/ processes being patented in Indian Patent office.
A Member of the American Chemical Society, Dr.MSN as an inventor has 167 Patent Publications globally (out of which 73 have been granted) and 53 research publications in reputed Indian as well as International journals.
His outstanding work as an entrepreneur and contribution to Indian Pharmaceutical Sector gained nationwide recognition. He has been conferred with many prestigious awards like Udyog Ratan Award by the Institute of Economic Studies for employment generation and TV5 Business Leader Award for his exceptional services to the Pharmaceutical Industry.
His strategic vision and deep business insights have set MSN Group on a seamless path of progress. Under his able leadership, it has achieved numerous milestones. Today, the group has a total of 21 State-of-the-art Manufacturing and Research & Development facilities in India and abroad. These include 14 Active Pharmaceutical Ingredients facilities, 6 Formulations facilities and 1 Research & Development Centre spread across India and USA. The Group has marketing and subsidiary offices in major markets like USA, UK, Canada, Mexico, Colombia, Chile, Peru, UAE, Malaysia, Kenya and Vietnam among others.
The organisation recognised for its innovation, quality and speed of delivery, owns a vast product portfolio of 450+APIs and 300+Finished Dosages covering a broad spectrum of 35+ therapeutic domains including Oncology, Cardiology, CNS, Diabetes, Nephrology, Urology, Gastroenterology and Orthopaedics etc.
The MSN Group has filed around 836 patent applications globally and has been granted with 144 patents. The Group with a total of 1000+Global DMFs is also World’s No.1 in active US DMF Filings. The group has to its credit a total of 144 ANDAs (Abbreviated New Drug Applications) and 51+ First-to-Files apart from over 4861 Finished Product Dossiers worldwide with 2074 approvals.
In addition to being an astute entrepreneur, Dr MSN is a modest and compassionate individual who deeply cares for community, environment, and heritage. It is this inherent trait which led Dr MSN to inspire and encourage a host of CSR activities which have made a meaningful difference to communities where the group operates in. The activities in a nutshell include: Tree Plantations, Drinking Water Supply & Conservation initiatives, Free Distribution of Books, Renovation of Schools and infrastructure support, Rural infrastructure development including roads, underground drainage and street lighting and Healthcare activities like free health check-up camps and free medicines’ distribution among others.
The Group has been at the forefront of supporting the renovation of ancient temples, important sites of pilgrimage and architectural significance in Telangana State, preserving the nation’s glorious cultural heritage. As a token of gratitude to his Alma Mater, Dr MSN recently made a significant contribution to the modernisation of the chemistry department at Osmania University to facilitate advanced research endeavours of the students.
He has given shape to MSN Group’s “Compassionate Medicine Programme” where orphan drugs are exclusively manufactured and delivered on a zero-profit basis to meet the needs of patients suffering from rare diseases like Duchenne muscular dystrophy, Relapsing Multiple Scelerosis and Wilson's disease etc.
It was during the Covid-19 pandemic, MSN Group under Dr MSN’s aegis played a key role in the global fight against the pandemic. Besides extending financial support to Telangana CM Relief Fund, the group swiftly developed and delivered a range of critical Covid-19 drugs at most affordable prices to the citizens across India. The Group has also delivered free medicines and protective gear to those on frontlines acknowledging their selfless service during the critical times.
Driven by the humane mission of enabling access to affordable high-quality medicines to the world, MSN Group under Dr MSN aims to continually expand its growth and global-footprint.
Executive Director - MSN Group
Bharat Reddy is the Executive Director of the MSN Group of companies. An accomplished technocrat with an experience of over 20 years, Bharat has displayed his adeptness in handling profiles including information technology, life science and pharmaceuticals.
Bharat holds an exemplary academic record with a Master’s degree in Business Administration from the University of Florida, Masters in Computer Science from Florida Atlantic University and a third Masters from Clemson University.
As an Executive Director, Bharat plays a significant role in MSN’s global pharmaceutical operations, sales and marketing. His expertise in developing market-specific business strategies coupled with strong emphasis on creating brand identity, has helped MSN Group mark its presence worldwide.
Overseeing the overall business development of MSN group, Bharat leads the operations of the formulation business, Information Technology and new avenues for MSN group worldwide.
We are extremely grateful for the wonderful family of clients and customers that we have built across the globe.